“…After blocking of nonspecific sites, blots were incubated with primary antibodies against NF-B RelA (A, sc-109, 1:500; Santa Cruz Biotechnology, CA, USA), IRAK1 (F-4, sc-5288, 1:1,000; Santa Cruz Biotechnology), IB␣ (6A920, 1:500; Abcam, Cambridge, United Kingdom), phospho-IB␣ (39A1431, sc-52943; 1:500; Santa Cruz Biotechnology), cyclin D1 (H-295, sc-753, 1:1,000; Santa Cruz Biotechnology), FLAG (D-8, sc-807, 1:500; Santa Cruz Biotechnology), transcription factor IIB (TF-IIB, sc-23875, 1:2,000; Santa Cruz Biotechnology), -actin (AC-15, 1:10,000; Abcam), and p21 WAF1 (F-5, sc-6246, 1:500; Santa Cruz Biotechnology) overnight at 4°C. BARF1 antibody (monoclonal antibody [MAb] 4A6, 1:100) was supplied by Middeldorp (28,30,(32)(33)(34). Blots were washed and incubated for 120 min at room temperature with horseradish peroxidase-conjugated anti-mouse secondary antibody (Abcam).…”